DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
DarioHealth has raised $23.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2026.
DarioHealth's investors include OurCrowd, Perceptive Advisors, OrbiMed, Farallon Capital Management, Soleus Capital.
DarioHealth is headquartered in New York, United States.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
DarioHealth is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DarioHealth — Funding & Investors." VCBacked, July 22, 2026, https://www.vcbacked.co/company/dariohealth. Accessed November 11, 2026.
VCBacked. (2026). DarioHealth — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/dariohealth
{{cite web |title=DarioHealth — Funding & Investors |url=https://www.vcbacked.co/company/dariohealth |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at DarioHealth? Request a listing update